Photo of: Valerie Barton

Ms. Valerie Barton

View Title...

Avalere Health LLC
Washington , Dc, District of Columbia
Valerie's profile was created using:
Sort By:

1-10 of 12 online sources for Valerie Barton

  • View Online Source
    www.healtheconomics.org/jobs/2007/04/12/health-economis - [Cached Version]
    Published on: 1/1/2007    Last Visited: 3/3/2007  

    Valerie Barton, Director Data Analytics Practice 1350 Connecticut Ave., NW Suite 900 Washington, DC 20036

  • View Online Source
    www.healtheconomics.org/jobs/2007/04/12/index.html - [Cached Version]
    Published on: 1/1/2007    Last Visited: 3/3/2007  

    Valerie Barton, Director Data Analytics Practice 1350 Connecticut Ave., NW Suite 900 Washington, DC 20036

    ,,,,,,n,,v,,,,e,e,,,,,,e,

  • View Online Source
    www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/w - [Cached Version]
    Published on: 3/13/2008    Last Visited: 3/13/2008  

    of, drugs to Medicare beneficiaries," said Valerie Barton, vice president of Avalere Health and co-author of the study.
    ...
    Barton.
    ...
    According to Barton, this type of research is currently not feasible.
    ...
    Karaca, Sonya B. Streeter, Valerie Barton, Khoa Nguyen, and Kris Norris,

  • View Online Source
    www.ispor.org/employment/JobDetails.aspx?guid=b1eddf98- - [Cached Version]
    Published on: 3/3/2007    Last Visited: 3/3/2007  

    Attention: Valerie BartonDirectorData Analytics Practice1350 Connecticut Ave., NWSuite 900Washington, DC 20036vbarton@avalerehealth.net

  • View Online Source
    Avalere Health - Staff - [Cached Version]
    Published on: 11/5/2008    Last Visited: 11/5/2008  

    Valerie Barton

    Valerie Barton, Vice President, leads Avalere's Data Analytics, which works as a complement to the firm's strategic advisory services by using public and proprietary datasets, including Avalere's DataFrameÔ database, to model the impact of policy change on both clients' businesses and the federal budget. Valerie has more than 10 years of experience in health policy analysis and strategy development.

    Prior to joining Avalere, Valerie was a Senior Manager with The Lewin Group, where she directed large, multi-year projects on hospital payment and staffing, evidence-based medicine, and medical technologies for both private and public sector clients. Valerie has extensive experience in Medicare payment policy, having worked in the federal government to develop and launch Medicare prospective payment systems for hospital outpatient departments, skilled nursing facilities, and inpatient rehabilitation facilities.

    Valerie received a M.A. in Economics from the Pennsylvania State University and graduated Phi Beta Kappa with a B.A. in Economics and East Asian Studies from the University of Pittsburgh.

  • View Online Source
    Avalere Health Releases Comprehensive Medicare... - [Cached Version]
    Published on: 2/6/2006    Last Visited: 9/3/2008  

    "Consumers will have a broad range of plans to choose from in 2006," said Valerie Barton, a Medicare expert at Avalere Health."Plans entered this untested marketplace with a variety of strategies and will likely alter their benefit designs and business strategies moving forward.We expect to see marked changes in benefit offerings, including market consolidation, as plans course-correct based on experience and legislative and regulatory changes."

    The full report, "Understanding the 2006 Medicare Part D Marketplace," is available for purchase at http://www.avalerehealth.net/Medicare2006PartD/index.html.For more information on Avalere's DataFrame Part D database and Medicare marketplace analysis, contact Valerie Barton at vbarton@avalerehealth.net.

  • View Online Source
    Avalere Study Shows Medicare Part D Helping People... - [Cached Version]
    Published on: 3/12/2008    Last Visited: 11/5/2008  

    "Part D is meeting its goals of increasing access to, and affordability of, drugs to Medicare beneficiaries," said Valerie Barton, vice president of Avalere Health and co-author of the study.
    ...
    "Knowing when people with diabetes may hit the coverage gap is important for physicians who can look for signs of non-compliance, and for individuals who can use this data for financial planning purposes," said Barton. "The lack of change in the number of prescription drugs used invites more research on whether patients with type 2 diabetes tend to enroll in Part D plans that offered gap coverage, the financial sensitivity of patients with chronic illness, and generic switching patterns for patients in the coverage gap."

    The Avalere study did not evaluate if Medicare drug coverage has translated into improved health for seniors with Medicare drug coverage. According to Barton, this type of research is currently not feasible.

    "Regrettably, outcomes research on the Medicare population post-Part D implementation is hindered by the lack of integrated data from Medicare Part A, B, and D. Policymakers should consider the value of this type of integrated medical and pharmacy claims dataset and work fast to make it available to enable a deeper evaluation of Part D's success or shortcomings."

    Avalere used its proprietary DataFrame database of Part D plan benefit and formulary designs to characterize access to diabetes-related drugs in Part D and Wolters Kluwer's Source Lx, a nationally representative claims data repository, to analyze drug utilization and out-of-pocket costs from January 1, 2004 through September 30, 2007.

    "The Impact of Medicare Part D on Beneficiaries with Type 2 Diabetes: Drug Utilization and Out-of-Pocket Expenses," was authored by Zeynal Karaca, Sonya B. Streeter, Valerie Barton, Khoa Nguyen, and Kris Norris, all of Avalere Health.

  • View Online Source
    Avalere and American Cancer Society Host Medicare Part... - [Cached Version]
    Published on: 12/11/2007    Last Visited: 11/5/2008  

    "Changes in 2008 - such as increased premiums, heightened cost-sharing, and the transition of over 2 million dual eligibles into new drug plans - can have a major impact on certain patients that are heavily reliant on prescription drugs," said Valerie Barton, vice president of Avalere Health.

    Using its proprietary DataFrame® database, Avalere has analyzed the evolution of the Medicare drug benefit since its implementation in 2006. The firm tracks trends in drug coverage and pricing at the therapeutic and drug-specific level, and in enrollment patterns for the market at large and specific populations such as low-income beneficiaries.

  • View Online Source
    Medicare Congress: Home - [Cached Version]
    Published on: 4/3/2005    Last Visited: 11/14/2007  

    Valerie BartonDirector, Avalere Health LLC, Washington, DC

  • View Online Source
    Staff - Intersection of Business Strategy and Public... - [Cached Version]
    Published on: 11/5/2008    Last Visited: 11/5/2008  

    Valerie Barton
    ...
    Valerie Barton

Page:  1 2 Next

Wrong Person?

Try these instead
Related searches
More...
For Recruiters For Sales Pros

Copyright © 2008 Zoom Information Inc. All rights reserved.

BBeachHead-Oct08_RC001_P020.1 OM14